38
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Trp64Arg polymorphism of the β3-adrenergic receptor gene, pre-pregnancy obesity and risk of pre-eclampsia

, , &
Pages 19-28 | Received 29 Mar 2004, Accepted 20 Aug 2004, Published online: 07 Jul 2009
 

Abstract

Objective: Trp64Arg polymorphism of the β3-adrenergic receptor (β3-AR) gene was reported to be associated with increased risk of obesity and insulin resistance. Both traits have been implicated in the epidemiology and pathogenesis of pre-eclampsia. We investigated the relation of the β3-AR gene to pre-pregnancy obesity and risk of pre-eclampsia. The present study is a case-control study of 87 Caucasian pre-eclampsia cases and 214 controls.

Methods: Logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI), adjusted for maternal age and parity. Normotensive carriers of the variant allele (i.e. Arg64 allele) were 3.6 times more likely to be obese (body mass index (BMI) ⩾ 30 kg/m2) as compared with women not carrying the variant allele (OR = 3.6, 95% CI 0.8–15.0).

Results: Arg64 allele was more frequent in controls as compared with pre-eclampsia cases (11.7 vs. 5.3%, p < 0.01). After adjusting for age and parity, carriers experienced a 60% reduction in risk of pre-eclampsia (OR = 0.4, 95% CI 0.2, 0.9) as compared with women not carrying this allele. The association between carriage of the variant allele and risk of pre-eclampsia appeared to be modified by maternal BMI. Compared with lean carriers, lean women without the variant allele experienced only a small increase in the risk of pre-eclampsia (OR = 1.5; 95% CI: 0.6, 3.9). The OR for overweight women without the variant allele was 7.3 (95% CI 2.7–19.2).

Conclusions: Our results suggest a puzzling relationship between the polymorphism and the risk of pre-eclampsia. Future studies are needed to confirm these findings.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.